Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2007

01.12.2007 | Original Paper

Recurrent Giant Hemangioma Causing Severe Respiratory Distress

verfasst von: Fabrizio Romano, Grazia Messinesi, Francesco Tana, Franco Uggeri

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Hemangioma is a common benign tumor of the liver that is usually asymptomatic. If >4 cm (giant hemangioma), it could present symptoms related to bleeding, thrombosis, comsumptive coagulopathy, or adjacent abdominal organ compression. If symptomatic surgical treatment should be considered, liver resection as well as enucleation are considered. Recurrences after surgical resection are rare. We herein present a case of woman admitted to the emergency room for acute severe respiratory distress. She had undergone 2 surgical resections of liver hemangiomas. The respiratory syndrome, as showed by chest x-ray, computed tomography scan, and nuclear magnetic resonance imaging, was related to a recurrent giant multiple hemangioma, creating a prominent compression of right lung with left mediastinal shift and left heart dislocation. It resulted in pulmonary parenchymal compression associated with reduced chest wall compliance and increased pulmonary pressure. The patient was not eligible for surgical treatment because of the disease extension and her clinical conditions. She died 6 months later from respiratory insufficiency and hypercapnic coma.
Literatur
1.
Zurück zum Zitat Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59:995–1013PubMed Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59:995–1013PubMed
2.
Zurück zum Zitat Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A (1991) Natural history of hepatic hemangiomas: clinical and ultrasound study. Gut 32:677–680PubMedCrossRef Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A (1991) Natural history of hepatic hemangiomas: clinical and ultrasound study. Gut 32:677–680PubMedCrossRef
3.
Zurück zum Zitat Nichols FC, Van Heerden JA, Welland LH (1989) Benign liver tumors. Surg Clin North Am 69:297–314PubMed Nichols FC, Van Heerden JA, Welland LH (1989) Benign liver tumors. Surg Clin North Am 69:297–314PubMed
4.
Zurück zum Zitat Saegusa T, Ito K, Oba N (1995) Enlargement of multiple cavernous hemangioma of the liver, association with pregnancy. Intern Med 34:207–211PubMed Saegusa T, Ito K, Oba N (1995) Enlargement of multiple cavernous hemangioma of the liver, association with pregnancy. Intern Med 34:207–211PubMed
5.
Zurück zum Zitat Herman P, Costa MLV, Machado MAC, Pugliese V, D'Albuquerque LAC, Machado MCC, Gama-Rodriguez JJ, Saad WA (2005) Management of hepatic hemangiomas: a 14 year experience. J Gastrointest Surg 9:853–859PubMedCrossRef Herman P, Costa MLV, Machado MAC, Pugliese V, D'Albuquerque LAC, Machado MCC, Gama-Rodriguez JJ, Saad WA (2005) Management of hepatic hemangiomas: a 14 year experience. J Gastrointest Surg 9:853–859PubMedCrossRef
6.
Zurück zum Zitat Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, DeMatteo RP (2003) Diagnosis, management and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 197:392–402PubMedCrossRef Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, DeMatteo RP (2003) Diagnosis, management and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 197:392–402PubMedCrossRef
7.
Zurück zum Zitat Farges O, Daradkeh S, Bismuth H (1995) Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 19:19–24PubMedCrossRef Farges O, Daradkeh S, Bismuth H (1995) Cavernous hemangiomas of the liver: are there any indications for resection? World J Surg 19:19–24PubMedCrossRef
8.
Zurück zum Zitat Hall GW (2001) Kasabach-Merritt syndrome: pathogenesis and management. Br J Hematol 112:851–862CrossRef Hall GW (2001) Kasabach-Merritt syndrome: pathogenesis and management. Br J Hematol 112:851–862CrossRef
10.
Zurück zum Zitat Tsai HP, Jeng LB, Lee WC, Chen MF (2003) Clinical experience of hepatic hemangioma undergoing hepatic resection. Dig Dis Sci 48:916–920PubMedCrossRef Tsai HP, Jeng LB, Lee WC, Chen MF (2003) Clinical experience of hepatic hemangioma undergoing hepatic resection. Dig Dis Sci 48:916–920PubMedCrossRef
11.
Zurück zum Zitat Ozden I, Emre A, Alper A, Tunaci M, Acarli K, Bilge O, Tekant Y, Ariogul O (2000) Long term results of surgery for liver hemangiomas. Arch Surg 135:978–981PubMedCrossRef Ozden I, Emre A, Alper A, Tunaci M, Acarli K, Bilge O, Tekant Y, Ariogul O (2000) Long term results of surgery for liver hemangiomas. Arch Surg 135:978–981PubMedCrossRef
12.
Zurück zum Zitat Hanazaki K, Kajikawa S, Matsushita A, Monma T, Koide N, Nimura Y, Yazawa K, Watanabe H, Nishio A, Adachi W, Amano J (1999) Hepatic resection of giant cavernous hemangioma of the liver. J Clin Gastroenterol 29:257–260PubMedCrossRef Hanazaki K, Kajikawa S, Matsushita A, Monma T, Koide N, Nimura Y, Yazawa K, Watanabe H, Nishio A, Adachi W, Amano J (1999) Hepatic resection of giant cavernous hemangioma of the liver. J Clin Gastroenterol 29:257–260PubMedCrossRef
13.
Zurück zum Zitat Glinkova V, Shevah O, Boaz M, Levine A, Shirin H (2004) hepatic hemangiomas: possible association with female sex hormones. Gut 53:1352–1355PubMedCrossRef Glinkova V, Shevah O, Boaz M, Levine A, Shirin H (2004) hepatic hemangiomas: possible association with female sex hormones. Gut 53:1352–1355PubMedCrossRef
14.
Zurück zum Zitat Kim DY, Pantelic MV, Yoshida A, Jerius J, Aboulijoud M (2005) Cavernous hemangioma presenting as Budd-Chiari Syndrome. J Am Coll Surg 200:470–471PubMedCrossRef Kim DY, Pantelic MV, Yoshida A, Jerius J, Aboulijoud M (2005) Cavernous hemangioma presenting as Budd-Chiari Syndrome. J Am Coll Surg 200:470–471PubMedCrossRef
15.
Zurück zum Zitat Shimizu M, Miura J, Otoh H, Saitoh Y (1990) Hepatic giant cavernous hemangioma with microangiopatic haemolytic anemia and consumption coagulopathy. Am J Gastroenterol 85:1411–1413PubMed Shimizu M, Miura J, Otoh H, Saitoh Y (1990) Hepatic giant cavernous hemangioma with microangiopatic haemolytic anemia and consumption coagulopathy. Am J Gastroenterol 85:1411–1413PubMed
16.
Zurück zum Zitat Corigliano N, Mercantini P, Amodio PM, Balducci G, Caterino S, Ramacciato G, Ziparo V (2003) Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: report of a case. Surg Today 33:459–463PubMedCrossRef Corigliano N, Mercantini P, Amodio PM, Balducci G, Caterino S, Ramacciato G, Ziparo V (2003) Hemoperitoneum from a spontaneous rupture of a giant hemangioma of the liver: report of a case. Surg Today 33:459–463PubMedCrossRef
17.
Zurück zum Zitat Lerner SM, Hiatt JR, Salamandra J, Chen PW, Farmer DG, Ghobrial RM, Busuttil RW (2003) Giant cavernous liver hemangiomas. Effect of operative approach on outcome. Arch Surg 139:818–823CrossRef Lerner SM, Hiatt JR, Salamandra J, Chen PW, Farmer DG, Ghobrial RM, Busuttil RW (2003) Giant cavernous liver hemangiomas. Effect of operative approach on outcome. Arch Surg 139:818–823CrossRef
18.
Zurück zum Zitat Gedaly R, Pomposelli JJ, Pomfret EA, Lewis WD, Jenkins RL (1999) Cavernous hemangioma of the liver: anatomic resection versus enucleation. Arch Surg 134:407–411PubMedCrossRef Gedaly R, Pomposelli JJ, Pomfret EA, Lewis WD, Jenkins RL (1999) Cavernous hemangioma of the liver: anatomic resection versus enucleation. Arch Surg 134:407–411PubMedCrossRef
19.
Zurück zum Zitat Demircan O, Demiryurek, Yagmur O (2005) Surgical approach to symptomatic giant cavernous hemangioma of the liver. Hepatogastroenterology 52:183–186PubMed Demircan O, Demiryurek, Yagmur O (2005) Surgical approach to symptomatic giant cavernous hemangioma of the liver. Hepatogastroenterology 52:183–186PubMed
20.
Zurück zum Zitat Shimizu S, Takayama T, Kosuge T, Yamamoto J, Shimada K, Yamazaki S, Hasegawa H, Makuuchi M (1992) Benign tumors of the liver resected because of a diagnosis of malignancy. Surg Gynecol Obstet 174:403–407PubMed Shimizu S, Takayama T, Kosuge T, Yamamoto J, Shimada K, Yamazaki S, Hasegawa H, Makuuchi M (1992) Benign tumors of the liver resected because of a diagnosis of malignancy. Surg Gynecol Obstet 174:403–407PubMed
21.
Zurück zum Zitat Borgonovo G, Razzetta F, Arezzo A, Torre G, Mattioli F (1997) Giant hemangiomas of the liver: surgical treatment by liver resection. Hepatogastroenterology 44:231–234PubMed Borgonovo G, Razzetta F, Arezzo A, Torre G, Mattioli F (1997) Giant hemangiomas of the liver: surgical treatment by liver resection. Hepatogastroenterology 44:231–234PubMed
Metadaten
Titel
Recurrent Giant Hemangioma Causing Severe Respiratory Distress
verfasst von
Fabrizio Romano
Grazia Messinesi
Francesco Tana
Franco Uggeri
Publikationsdatum
01.12.2007
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2007
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9427-3

Weitere Artikel der Ausgabe 12/2007

Digestive Diseases and Sciences 12/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.